Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers (CROSBI ID 218523)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bezić, Joško ; Šamija Projić, Ivana ; Projić, Petar ; Ljubković, Jelena ; Zekić Tomaš, Sandra ; Meljanac Salopek, Kristina ; Piljić Burazer, Marina ; Tomić, Snježana Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers // Virchows archiv, 466 (2015), 2; 185-189. doi: 10.1007/s00428-014-1694-3

Podaci o odgovornosti

Bezić, Joško ; Šamija Projić, Ivana ; Projić, Petar ; Ljubković, Jelena ; Zekić Tomaš, Sandra ; Meljanac Salopek, Kristina ; Piljić Burazer, Marina ; Tomić, Snježana

engleski

Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers

The aim of the study was to explore possible differences in DNA flow cytometric characteristics, particularly differences in distribution of DNA indices of aneuploid clones, between male and female breast cancers. We retrospectively analyzed 31 male breast cancers. Clinicopathological and DNA flow cytometric characteristics of male breast cancers (patient age, tumor size, histological type, histological grade, axillary lymph node status, hormone receptor expression, ploidy, and Sphase fraction) were compared with that of the control group of matched female breast cancers. Hormone receptors and HER-2/ neu were investigated immunohistochemically with additional chromogenic in situ hybridization (CISH) analysis of HER-2/ neu 2+ cases. Ploidy and S-phase fraction were determined by DNA flow cytometry. Comparison with clinicopathological features was made using χ2 and t test. Aneuploidy was found in 78 % of the cases, with the predomination of hypotetraploid clones (39 %), followed by tetraploid (23 %) and hypertetraploid clones (16 %). We found higher frequency of hypertetraploidy in male breast cancers (16 and 6 %, respectively) than in the control group of matched female breast cancers. Clinicopathological features of hypertetraploid male breast cancers did not differ from that of non-hypertetraploid cancers. Higher frequency of hypertetraploidy among male breast cancers might indicate different cytogenetical evolutionary pathway between male and female breast cancer.

male breast cancer; female breast cancer; DNA flow cytometry; ploidy; hypertetraploidy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

466 (2)

2015.

185-189

objavljeno

0945-6317

10.1007/s00428-014-1694-3

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost